NephroPlus IPO Analyzed

NephroPlus, India’s biggest dialysis service provider, is getting ready to go public – it’s planning an IPO that starts on December 10th. This is happening because more people around the world are getting kidney problems, and there’s a growing need for places that can help them with dialysis. This IPO is a big opportunity for investors and a chance to support a company addressing a serious healthcare issue.

Key Points

• NephroPlus IPO opens Dec 10, closes Dec 12.
• Anchor investors can bid Dec 9th, one day early.
• Price range: Rs 438 – Rs 460 per share.
• Raises approx. Rs 871 crore at the high end.
• Mix of new shares and existing shareholders selling.
• Largest dialysis network, 519 global clinics across 21 countries.

The IPO will allow NephroPlus to raise around Rs 871 crore if they sell shares at the highest price. They’re planning to use this money to build more dialysis centers in India and in other countries, as well as pay off some debts. The IPO is a mix of selling new shares and existing shareholders selling some of their own.

NephroPlus has a huge network, with more than 500 clinics in 21 different countries, including India, the Philippines, Uzbekistan, Nepal, and Saudi Arabia. Their Tashkent facility in Uzbekistan is the biggest dialysis center in the world. This wide network shows how important it is for them to grow and reach more people who need help.

NephroPlus is specifically focusing on smaller towns and cities – tier-2 and tier-3 locations – because people need dialysis regularly, and there aren’t always enough specialized centers nearby. This is a smart way to make healthcare easier for more people.

In their last financial year (FY25), NephroPlus made around Rs 755.8 crore in sales and earned Rs 67 crore in profit. This demonstrates the company’s financial strength and the growing demand for its services.

Looking ahead, NephroPlus wants to keep expanding, but they also want to improve the quality of care and even try to prevent kidney disease in the first place. This long-term vision is about making a real difference in people’s lives.

“With only 10 percent of patients in India who reach CKD stage 5 currently receiving dialysis, the need for accessible, high-quality services is immense.”